Table of Content


FIGURES AND TABLES
PART 1. INTRODUCTION
? Report description
? Objectives of the study
? Market segment
? Years considered for the report
? Currency
? Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
? Introduction
? Drivers
? Restraints
? Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY INDICATION
? Parkinson’s disease
? Alzheimer’s disease
? Multiple sclerosis
? Huntington’s disease
? Others
PART 6. MARKET BREAKDOWN BY DRUG
? N-methyl-D-aspartate receptor antagonist
? Cholinesterase inhibitor
? Dopamine agonist
? Immunomodulatory drug
? Others
PART 7. MARKET BREAKDOWN BY REGION
? North America
? Europe
? Asia-Pacific
? MEA (Middle East and Africa)
? Latin America
PART 8. KEY COMPANIES
? Abbvie Inc.
? Amneal Pharmaceuticals Inc.
? Biogen Inc.
? Boehringer Ingelheim International GmbH
? Merck & Co. Inc.
? Novartis AG
? Pfizer Inc.
? Roche Holding AG
? Teva Pharmaceuticals Ltd.
? UCB S.A.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER